TY  - GEN
AU  - Kennedy,Ben
AU  - Rawstron,Andy
AU  - Carter,Chris
AU  - Ryan,Mary
AU  - Speed,Kevin
AU  - Lucas,Guy
AU  - Hillmen,Peter
TI  - Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia
SN  - 0006-4971
PY  - 2002///0523
KW  - Adult
KW  - Aged
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bone Marrow
KW  - pathology
KW  - Drug Resistance
KW  - Humans
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Remission Induction
KW  - Therapeutic Equivalency
KW  - Treatment Outcome
KW  - Vidarabine
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood.v99.6.2245
ER  -